zepbound glp-1 receptor agonist hydration effects 2025 Lilly orforglipron oral phase 3 weight loss trial GLP-1 & Gut - How

Aboud, S

This makes it a significant molecule in combating the signs of ageing and maintaining overall cellular health

J Clin Invest 2007

Molecular Brain study confirmed that MGF overexpression significantly increased the number of proliferative cells (BrdU+) in the dentate gyrus of the hippocampus and subventricular zone the primary adult neurogenic niches establishing that MGF promotes adult hippocampal neurogenesis

After announcing the state would initiate coverage of GLP-1s to combat obesity in September 2022 as part of their state employee health plan, the state reversed course and in January 2025 announced it was opting to end that coverage beginning July 1, 2025

,